Study led by Dan Barouch, Director of BIDMC's Center for Virology and Vaccine Research, and colleagues shows single-shot COVID-19 vaccine provides robust protection against SARS-CoV-2 variants identified in South Africa, the U.K., Brazil and California. (Beth Israel Deaconess Medical Center, June 9, 2021)
Beth Israel Lahey Health welcomes all community members to our walk-in COVID-19 vaccination clinics. No insurance required. Find a location near you.
Beth Israel Lahey Health leaders share what they've learned on vaccine and health equity from the health system’s COVID-19 vaccination effort. Read their takeaways here. (Beth Israel Lahey Health, April 8, 2021)
We know our patients have questions about the availability, safety and effectiveness of COVID-19 vaccines. Here is the latest information available.
Some Americans say they are finding ways to get additional doses of the COVID-19 vaccines, with some even going as far as receiving the extra shots from different companies. Dan Barouch, MD, PhD of Beth Israel Deaconess Medical Center said there’s limited data on the safety or efficacy of this approach and that there are theoretical benefits in terms of the immune responses and potential improvement of efficacy. (CNBC, July 26, 2021)
Preeti Mehrotra, MD of Beth Israel Deaconess Medical Center spoke about healthcare organizations requiring the COVID-19 vaccine for employees and said the COVID-19 vaccine is the best protection against the Delta variant. (WCVB, July 26, 2021)
Beverly Hospital is seeing very low COVID-19 hospitalization rates and no more than a couple of new cases arriving daily. But Mark Gendreau, MD of Beverly & Addison Gilbert Hospitals said that as a more contagious Delta variant of the coronavirus accounts for 83% of cases in the U.S., there are still roughly 100 million people who have either not had the vaccine or don’t have any form of natural immunity from having COVID infection. (Gloucester Daily Times, July 25, 2021)
While the CDC reminded consumers to not use commercial antibody tests to check whether or not they are immune to COVID-19, scientists are still searching for a "correlate of protection" – a marker in the blood that would reliably indicate protection. Dan Barouch, MD, PhD of Beth Israel Deaconess Medical Center said the correlates of protection are not known, and so it is not known whether a positive antibody test after COVID-19 infection represents protection against any variant, including the delta variant. (ABC, July 24, 2021)
The rise in Covid-19 cases nationwide due to the new, more-contagious Delta variant is spurring some Boston-area employers to rethink plans to come back after Labor Day. While continuing to monitor the situation, Beth Israel Lahey Health currently plans to bring many employees who have been working remotely back to the office on a part-time basis starting Sept. 7. (Boston Business Journal, July 23, 2021)
Scientists may be on the cusp of defining correlates – biological benchmarks that can show that a vaccine is achieving its desired effect – of protection against symptomatic disease for the COVID-19 vaccines. Kathryn Stephenson, MD, MPH of Beth Israel Deaconess Medical Center comments on the process and timeline of these determinations. (Atlantic, July 21, 2021)
Findings posted on the online preprint server bioRxiv suggest the coronavirus vaccine made by Johnson & Johnson is less effective against the Delta and Lambda variants than against the original virus. The study has not yet been peer-reviewed nor published in a scientific journal. Last week, researchers from Beth Israel Deaconess Medical Center reported in the New England Journal of Medicine that the antibody response from the Johnson & Johnson vaccine did work well against the delta variant and that the immune response lasted eight months. (NBC News, July 21, 2021)
In this commentary article published in WBUR’s “Cognoscenti,” Adam Stern, MD of Beth Israel Deaconess Medical Center shared his experience with coping with cancer throughout the pandemic. (WBUR, July 20, 2021)